Melatonin metabolism in health and disease of the gastrointestinal tract (literature review)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The purpose of the article was to summarize modern data concerning physiological effects of melatonin in general and its influence at the gastrointestinal tract, in particular, on the basis of domestic and foreign scientific articles published over the past 7 years. The role of this hormone in the pathogenesis and prognostication of chronic gastritis and peptic ulcer course is highlighted, the results and perspectives of using medicines on it's base in case of functional and organic pathology of the digestive system are outlined. The authors make a conclusion, that, despite a large number of thematic works, the problem of identifying the causes and methods of correcting abovementioned gastrointestinal diseases has not been finally resolved and requires further studies. In addition, the annually increasing number of complications in patients with gastrointestinal tract pathology and the development of antibiotic resistance associated with anti-Helicobacter therapy pose new challenges for improving approaches for elimination of symptoms and prevention of recurrence of peptic ulcer and chronic gastritis. These approaches, among other things, include the use of melatonin in complex therapy, and require further targeted study.

Full Text

Restricted Access

About the authors

Luiza N. Musaeva

Dagestan State Medical University of the Ministry of Healthcare of Russia

postgraduate student, senior laboratory assistant of the Department of hospital therapy No. 2

Esed M. Esedov

Dagestan State Medical University of the Ministry of Healthcare of Russia

MD, professor, head of the Department of hospital therapy No. 2

Albina S. Abasova

Dagestan State Medical University of the Ministry of Healthcare of Russia

PhD, associate professor of the Department of hospital therapy No. 2

Suleiman N. Mammaev

Dagestan State Medical University of the Ministry of Healthcare of Russia

MD, professor, head of the Department of hospital therapy No. 1

References

  1. Zaki N.F.W., Spence D.W., Subramanian P. et al. Basic chronobiology: what do sleep physicians need to know? Sleep Sci. 2020; 13(4): 256-66. doi: 10.5935/1984-0063.20200026.
  2. Семенова Н.В. Хронобиологические аспекты нарушений сна у женщин климактерического периода: роль мелатонина (обзор литературы). Acta biomedica scientifica (East Siberian Biomedical Journal). 2017; 5-1: 32-37. https://doi.org/10.12737/article_59e71aad2aa777.29348772.
  3. Chitimus D.M., Popescu M.R., Voiculescu S.E. et al. Melatonin's impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease. Biomolecules. 2020; 10(9): 1211. doi: 10.3390/biom10091211.
  4. Oxlund J., Knudsen T., Strom T. et al. Serum melatonin concentration in critically ill patients randomized to sedation or non-sedation. Ann Intensive Care. 2021; 11(1): 40. doi: 10.1186/s13613-021-00829-1.
  5. Bang C.S., Yang Y.J., Baik G.H. Melatonin for the treatment of gastroesophageal reflux disease; protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2019; 98(4): e14241. doi: 10.1097/MD.0000000000014241.
  6. Xie S., Fan W., He H., Huang F. Role of melatonin in the regulation of pain. J. Pain Res. 2020; 13: 331-43. doi: 10.2147/JPR.S228577.
  7. Hardeland R. Divergent importance of chronobiological considerations in high- and low-dose melatonin therapies. Diseases. 2021; 9(1): 18. doi: 10.3390/diseases9010018.
  8. Socaciu A.I., Ionut R., Socaciu M.A. et al. Melatonin, an ubiquitous metabolic regulator: functions, mechanisms and effects on circadian disruption and degenerative diseases. Rev Endocr Metab Disord. 2020; 21(4): 465-78. doi: 10.1007/s11154-020-09570-9.
  9. Slominski A.T., Zmijewski M.A., Semak I. et al. Melatonin, mitochondria, and the skin. Cell Mol Life Sci. 2017; 74(21): 3913-25. doi: 10.1007/s00018-017-2617-7.
  10. Pires-Lapa M.A., Carvalho-Sousa C.E., Cecon E. et al. Beta-adrenoceptors trigger melatonin synthesis in phagocytes. Int J. Mol Sci. 2018; 19(8): 2182. doi: 10.3390/ijms19082182.
  11. Cipolla-Neto J., Amaral F., Afeche S. et al. Melatonin, energy metabolism, and obesity: A review. J. Pineal Res. 2014; 56(4): 371-81. doi: 10.1111/jpi.12137.
  12. Арушанян Э.Б., Ованесов К.Б. Значение мелатонина для физиологии и патологии глаза. Медицинский вестник Северного Кавказа. 2016; 1: 126-133. doi: https://doi.org/10.14300/mnnc.2016.11017.
  13. Xia Y., Chen S., Zeng S. et al. Melatonin in macrophage biology: current understanding and future perspectives. J. Pineal Res. 2019; 66(2): e12547. doi: 10.1111/jpi.2019.66.issue-2.
  14. Xiao L., Hu J., Song L. et al. Profile of melatonin and its receptors and synthesizing enzymes in cumulus-oocyte complexes of the developing sheep antral follicle-a potential estradiol-mediated mechanism. Reprod Biol Endocrinol. 2019; 17(1): 1. doi :10.1186/ s12958-018-0446-7.
  15. Esteban-Zubero E., Lopez-Pingarron L., Alatorre-Jimenez M.A. et al. Melatonin's role as a co-adjuvant treatment in colonic diseases: A review. Life Sci. 2017; 170: 72-81. doi: 10.1016/j.lfs.2016.11.031.
  16. Mehrzadi S., Pourhanifeh M.H., Mirzaei A. et al. An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress. Cancer Cell Int. 2021; 21(1): 188. doi: 10.1186/s12935-021-01892-1.
  17. Xie W.Q., Chen S.F., Tao X.H. et al. Melatonin: Effects on cartilage homeostasis and therapeutic prospects in cartilage-related diseases. Aging and Disease. 2021; 12(1): 297-307. doi: 10.14336/ad.2020.0519.
  18. Boutin J.A., Ferry G. Is there sufficient evidence that the melatonin binding site MT3 is quinone reductase 2? J. Pharmacol Exp Ther. 2019; 368(1): 59-65. doi: 10.1124/jpet.118.253260.
  19. Cecon E., Oishi A., Jockers R. Melatonin receptors: Molecular pharmacology and signalling in the context of system bias. Br J. Pharmacol. 2018; 175(16): 3263-80. doi: 10.1111/bph.13950.
  20. Posa L., De Gregorio D., Gobbi G., Comai S. Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain. Curr Med Chem. 2018; 25(32): 3866-82. doi: 10.2174/0929867324666170209104926
  21. Cook D.N., Kang H.S., Jetten A.M. Retinoic acid-related orphan receptors (RORs): Regulatory functions in immunity, development, circadian rhythm, and metabolism. Nucl Receptor Res. 2015; 2: 101185. doi: 10.11131/2015/101185.
  22. Liu L., Labani N., Cecon E., Jockers R. Melatonin target proteins: Too many or not enough? Front Endocrinol (Lausanne). 2019; 10: 791. doi: 10.3389/fendo.2019.00791.
  23. Курганова Ю.М., Данилов А.Б. Роль мелатонина в терапии хронической головной боли. МС. 2018; 1: 33-37. doi: https://doi.org/10.21518/2079-701X-2018-1-33-37.
  24. Арушанян Э.Б., Бейер Э.В. Мелатонин: биология, фармакология, клиника. Монография. Ставрополь. 2015; 390 с.
  25. Арушанян Э.Б., Щетинин Е.В. Мелатонин как универсальный модулятор любых патологических процессов. Патологическая физиология и экспериментальная терапия. 2016; 1: 79-88.
  26. Reiter R.J., Mayo J.C., Tan D.X. et al. Melatonin as an antioxidant: Under promises but over delivers. J. Pineal Res. 2016; 61(3): 253-78. doi: 10.1111/jpi.12360.
  27. Tan D.X., Manchester L.C., Qin L., Reiter R.J. Melatonin: A mitochondrial targeting molecule involving mitochondrial protection and dynamics. Int J. Mol Sci. 2016; 17(12): 2124. doi: 10.3390/ijms17122124.
  28. Huo X., Wang C., Yu Z. et al. Human transporters, PEPT1/2, facilitate melatonin transportation into mitochondria of cancer cells: an implication of the therapeutic potential. J. Pineal Res. 2017; 62(4). doi: 10.1111/jpi.12390.
  29. Mayo J.C., Sainz R.M., Gonzalez-Menendez P. et al. Melatonin transport into mitochondria. Cell Mol Life Sci. 2017; 74(21): 3927-40. doi: 10.1007/s00018-017-2616-8.
  30. Bonmati-Carrion M.A., Tomas-Loba A. Melatonin and cancer: A polyhedral network where the source matters. Antioxidants (Basel). 2021; 10(2): 210. doi: 10.3390/antiox10020210.
  31. Bai J., Zhang L., Zhao Z. et al. Expression of melatonin receptors and CD4 in the ovine thymus, lymph node, spleen and liver during early pregnancy. Immunology. 2020; 160(1): 52-63. doi: 10.1111/imm.13180.
  32. Hardeland R. Divergent importance of chronobiological considerations in high- and low-dose melatonin therapies. Diseases. 2021; 9(1): 18. doi: 10.3390/diseases9010018.
  33. Borniger J.C., Cisse Y.M., Surbhi, Nelson R.J. Reciprocal regulation of circadian rhythms and immune function. Curr Sleep Medicine Rep. 2007; 3: 93-103. doi: 10.1007/s40675-017-0070-7.
  34. Tordjman S., Chokron S., Delorme R. et al. Melatonin: Pharmacology, functions and therapeutic benefits. Curr Neuropharmacol. 2017; 15(3): 434-43. doi: 10.2174/1570159X14666161228122115.
  35. Nabavi S.M., Nabavi S.F., Sureda A. et al. Anti-inflammatory effects of melatonin: A mechanistic review. Crit Rev Food Sci Nutr. 2018; 59(Suppl 1): 4-16. doi: 10.1080/10408398.2018.1487927.
  36. Liu Z., Gan L., Xu Y. et al. Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-KB/GSDMD signal in mice adipose tissue. J. Pineal Res. 2017; 63(1). doi: 10.1111/jpi.12414.
  37. Su S.C., Hsieh M.J., Yang W.E. et al. Cancer metastasis: mechanisms of inhibition by melatonin. J. Pineal Res. 2017; 62(1): e12370. doi: 10.1111/jpi.12370.
  38. Gurunathan S., Qasim M., Kang M.H., Kim J.H. Role and therapeutic potential of melatonin in various type of cancers. Onco Targets Ther. 2021; 14: 2019-52. doi: 10.2147/ott.s298512.
  39. Colombo J., Maciel J.M., Ferreira L.C. et al. Effects of melatonin on HIF-1a and VEGF expression and on the invasive properties of hepatocarcinoma cells. Oncol Lett. 2016; 12(1): 231-37. doi: 10.3892/ol.2016.4605.
  40. Kim H.B., Kim J.H. Sunlight exposure in association with risk of lymphoid malignancy: a meta-analysis of observational studies. Cancer Causes Control. 2021; 32(5): 441-57. doi: 10.1007/s10552-021-01404-6.
  41. Kvietkauskas M., Zitkute V., Leber B. et al. The role of melatonin in colorectal cancer treatment: a comprehensive review. Ther Adv Med Oncol. 2020; 12: 1758835920931714. doi: 10.1177/1758835920931714.
  42. Mayo J.C., Sainz R.M. Melatonin from an antioxidant to a classic hormone or a tissue factor: Experimental and clinical aspects 2019. Int J. Mol Sci. 2020; 21(10): 3645. doi: 10.3390/ijms21103645.
  43. Kopustinskiene D.M., Bernatoniene J. Molecular mechanisms of melatonin-mediated cell protection and signaling in health and disease. Pharmaceutics. 2021; 13(2): 129. doi: 10.3390/pharmaceutics13020129.
  44. Циммерман Я.С. Стойкие заблуждения современной гастроэнтерологии. Клиническая фармакология и терапия. 2016; 5: 5-13.
  45. Ивашкин В.Т., Маев И.В., Царьков П.В. с соавт. Диагностика и лечение язвенной болезни у взрослых (Клинические рекомендации Российской гастроэнтерологической ассоциации, Российского общества колоректальных хирургов и Российского эндоскопического общества). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2020; 1: 49-70. doi: https://doi.org/10.22416/1382-4376-2020-30-1-49-70.
  46. Григорьев К.И., Запруднов А.М., Харитонова А.А. Язвенная болезнь - историческая динамика взглядов на этиопатогенез и лечение с позиций педиатров. Экспериментальная и клиническая гастроэнтерология. 2019; 1: 1 55-165. doi: https://doi.org/10.31146/1682-8658-ecg-161-1-155-165.
  47. Волкова Н.И., Джериева И.С. Гастроэнтерология: учебное пособие. Ростов-на-Дону: Издательство РостГМУ. 2016; 161 с.
  48. Циммерман Я.С. Язвенная болезнь: критический анализ современного состояния проблемы. Экспериментальная и клиническая гастроэнтерология. 2018; 1: 80-89.
  49. Ahmed S., Belayneh Y.M. Helicobacter pylori and duodenal ulcer: systematic review of controversies in causation. Clin Exp Gastroenterol. 2019; 12: 441-47. doi: 10.2147/CEG.S228203.
  50. Li R., Boer C.G., Oei L., Medina-Gomez C. The gut microbiome: A new frontier in musculoskeletal research. Curr Osteoporos Rep. 2021; 19(3): 347-57. doi: 10.1007/s11914-021-00675-x.
  51. Shimizu Y. Gut microbiota in common elderly diseases affecting activities of daily living. World J. Gastroenterol. 2018; 24(42): 4750-58. doi: 10.3748/wjg.v24.i42.4750.
  52. Самойлова Ю.Г., Олейник О.А., Саган Е.В. с соавт. Состав и метаболическая активность микробиоты пищеварительной системы у детей и подростков с ожирением. Сибирский журнал клинической и экспериментальной медицины. 2020; 3: 38-46. doi: https://doi.org/10.29001/2073-8552-2020-35-3-38-46.
  53. Litovskij I.A., Gordienko A.V. Anti-Helicobacter pylori eradication therapy - a way out of the impasse or moving deeper into the labyrinth? Clin Pharmacol Ther. 2018; 27(5): 11-16. doi: 10.32756/0869-5490-2018-5-11-16.
  54. Циммерман Я.С., Захарова Ю.А. Киотский консенсус - новая этиологическая классификация хронического гастрита и ее обсуждение. Клиническая медицина. 2017; 2: 181-188. doi: http://dx.doi.org/10.18821/0023-2149-2017-95-2-181-188.
  55. Циммерман Я.С. Антибактериальная терапия и ее влияние на эндоэкологическую систему «макроорганизм - эндосимбионтные бактерии» (на примере Helicobacter pylori-ассоциированных заболеваний). Клиническая фармакология и терапия. 2015; 2: 5-12.
  56. Червинец В.М., Червинец Ю.В., Базлов С.Н. Микробиом эзофагогастродуоденальной зоны здоровых людей и при воспалительно-эрозивно-язвенных ее поражениях. Бюллетень Оренбургского научного центра УРО РАН. 2019; 3: 26.
  57. Хижкин Е.А., Илюха В.А., Виноградова И.А. Перестройки пищеварительной функции крыс, вызванные длительным постоянным освещением. Российский физиологический журнал им. И.М. Сеченова. 2018; 2: 238-247. doi: https://doi.org/10.1134/S0869813919020055.
  58. Hunter C.M., Figueiro M.G. Measuring light at night and melatonin levels in shift workers: A review of the literature. Biol Res Nurs. 2017; 19(4): 365-74. doi: 10.1177/1099800417714069.
  59. Lu X., Yu S., Chen G. et al. Insight into the roles of melatonin in bone tissue and bone related diseases (Review). Int J. Mol Med. 2021; 47(5): 82. doi: 10.3892/ijmm.2021.4915
  60. Acuna-Castroviejo D., Escames G., Venegas C. et al. Extra pineal melatonin: Sources, regulation, and potential functions. Cell Mol Life Sci. 2014; 71(16): 2997-3025. doi: 10.1007/s00018-014-1579-2.
  61. Jaworek J., Leja-Szpak A., Nawrot-Porabka K. et al. Effects of melatonin and its analogues on pancreatic inflammation, enzyme secretion, and tumorigenesis. Int J. Mol Sci. 2017; 18(5): 1014. doi: 10.3390/ijms18051014.
  62. Вапаев К.Б., Ирназаров Ш.О. Роль мелатонина в регуляции функции желудочно-кишечного тракта. Современные инновации. 2019; 1: 32-35.
  63. Chojnacki C., Medrek-Socha M., Konrad P. et al. The value of melatonin supplementation in postmenopausal women with Helicobacter pylori-associated dyspepsia. BMC Women's Health. 2020; 20(1): 262. doi: 10.1186/s12905-020-01117-z.
  64. Favero G., Franceschetti L., Bonomini F. et al. Melatonin as an anti-inflammatory agent modulating inflammasome activation. Int J. Endocrinol. 2017; 2017: 1835195. doi: 10.1155/2017/1835195.
  65. Andersen L.P.H., Gogenur I., Rosenberg J., Reiter R.J. The safety of melatonin in humans. Clin. Drug Investig. 2015; 36(3): 169-75. doi: 10.1007/s40261-015-0368-5.
  66. Baburina Y., Lomovsky A., Krestinina O. Melatonin as a potential multitherapeutic agent. J. Pers Med. 2021; 11(4): 274. doi: 10.3390/ jpm11040274.
  67. He F., Wu X., Zhang Q. et al. Bacteriostatic potential of melatonin: Therapeutic standing and mechanistic insights. Front Immunol. 2021; 12: 683879. doi: 10.3389/fimmu.2021.683879.
  68. Ford A.C., Gurusamy K.S., Delaney B. et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev. 2016; 4(4): CD003840. doi: 10.1002/14651858.CD003840.pub5.
  69. Li L., Zhao Z., Ma J. et al. Elevated plasma melatonin levels are correlated with the non-motor symptoms in Parkinson's disease: A cross-sectional study. Front Neurosci. 2020; 14: 505. doi: 10.3389/fnins.2020.00505. eCollection 2020.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies